<i>CHL1</i> , <i>ITGB3</i> and <i>SLC6A4</i> Gene Expression and Antidepressant Drug Response: Results from the Munich Antidepressant Response Signature (MARS) Study

Kristina Probst-Schendzielorz, Catharina Scholl, Olga Efimkina, Eva Ersfeld, Roberto Viviani, Alessandro Serretti, Chiara Fabbri, David Gurwitz, Susanne Lucae, Marcus Ising,

Pharmacogenomics · 2015 · 21 citations · 30 references

Abstract

CHL1 expression in patient-derived LCLs correlated with the clinical outcome. Thus, it could be a valid biomarker to predict the success of an antidepressant therapy. Original submitted 8 December 2014; Revision submitted 2 March 2015.

References

30